Details

Title
Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein
Author
Xia Shuai 1 ; Zhu, Yun 2 ; Liu Meiqin 3 ; Qiaoshuai, Lan 1 ; Xu, Wei 1 ; Wu, Yanling 1 ; Tianlei, Ying 1   VIAFID ORCID Logo  ; Liu, Shuwen 4 ; Shi Zhengli 3 ; Jiang Shibo 5 ; Lu, Lu 1   VIAFID ORCID Logo 

 Fudan University, Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Fudan-Jinbo Joint Research Center, Shanghai, China (GRID:grid.8547.e) (ISNI:0000 0001 0125 2443) 
 Chinese Academy of Sciences, National Laboratory of Biomacromolecules, Institute of Biophysics, Beijing, China (GRID:grid.9227.e) (ISNI:0000000119573309) 
 Chinese Academy of Sciences, CAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Wuhan, China (GRID:grid.9227.e) (ISNI:0000000119573309) 
 Southern Medical University, Guangdong Provincial Key Laboratory of New Drug Screening, Guangzhou Key Laboratory of Drug Research for Emerging Virus Prevention and Treatment, School of Pharmaceutical Sciences, Guangzhou, China (GRID:grid.284723.8) (ISNI:0000 0000 8877 7471) 
 Fudan University, Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Fudan-Jinbo Joint Research Center, Shanghai, China (GRID:grid.8547.e) (ISNI:0000 0001 0125 2443); New York Blood Center, Lindsley F. Kimball Research Institute, New York, USA (GRID:grid.250415.7) (ISNI:0000 0004 0442 2075) 
Pages
765-767
Publication year
2020
Publication date
Jul 2020
Publisher
Nature Publishing Group
ISSN
16727681
e-ISSN
20420226
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2419547296
Copyright
© The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.